Bcl-xL and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells | Zendy

Henning SchulzeBergkamen | Zendy; Roland Ehrenberg | Zendy; Lothar Hickmann | Zendy; Binje Vick | Zendy; Toni Urbanik | Zendy; C Schimanski | Zendy; Martin R. Berger | Zendy; Arno Schad | Zendy; Achim Weber | Zendy; S. Heeger | Zendy; Peter R. Galle | Zendy; Markus Moehler | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bcl-xL and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells

Author(s) -

Henning SchulzeBergkamen,

Roland Ehrenberg,

Lothar Hickmann,

Binje Vick,

Toni Urbanik,

C Schimanski,

Martin R. Berger,

Arno Schad,

Achim Weber,

S. Heeger,

Peter R. Galle,

Markus Moehler

Publication year - 2008

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.14.3829

Subject(s) - apoptosis , cancer research , biology , viability assay , cell culture , microbiology and biotechnology , downregulation and upregulation , transfection , programmed cell death , biochemistry , genetics , gene

To explore the role of Bcl-x(L) and Myeloid cell leukaemia (Mcl)-1 for the apoptosis resistance of colorectal carcinoma (CRC) cells towards current treatment modalities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research